Emicizumab in people with moderate or mild haemophilia AHAVEN 6 a multicentre open label singlearm phase 3 study - C Negrier; Johnny Mahlangu; M Lehle; P Chowdary; Olivier Catalani; E et al (WILEY-BLACKWELL, 2024)